Polls: Two Southern States Support Medical Marijuana

NORML reports on polling: In another sign of the changing times, this past week two new polls have been released demonstrating majority support for allowing the medical use of marijuana in two southern states, a region historically less supportive of cannabis law reforms.

A poll conducted by Public Policy Polling revealed that most North Carolinians believe that a doctor should possess the legal option to authorize marijuana for patients. Support for legalizing medical marijuana is at 58% overall, with 33% opposed and 9% undecided. A majority of every age group under age 65 supports allowing for the medical use of marijuana. The poll surveyed 608 North Carolina voters between January 10 and January 13, 2013.

Another Public Policy Polling survey had the majority of West Virginians supporting the medical use of cannabis, 53% in favor to 40% opposed. Further, when asked which is a safer treatment for debilitating pain: the medical use of marijuana or Oxycontin, 63% responded medical marijuana.

Georgia one of 1st states to allow medical marijuana

In 1980 Georgia General Assembly unanimously passed a medical marijuana research act, (Controlled Substance Therapeutic Research Act – Code 43-34-120) becoming one of the first states to recognize the medical benefits of marijuana. With support of Lt. Gov. Zell Miller, House Speaker Tom Murphy, Rep. Virlyn Smith and Governor George Busbee, this landmark legislation opened the doors to therapeutic cannabis. The law relied upon federal cooperation and supply, therefore rendering the law cumbersome and ineffective in accomplishing its goal to further the research into the benefits of medical marijuana.

The legislation stated: “(Studies) indicates that marijuana and certain of its derivatives possess valuable and in some cases, unique therapeutic properties, including the ability to relieve nausea and vomiting which routinely accompany chemotherapy and irradiation used to treat cancer patients.” It also cited the benefit in reducing intraocular pressure in glaucoma patients.